From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis

অনুযায়ী Bersanelli, Melissa, Buti, Sebastiano
প্রকাশিত World J Clin Oncol (2017)

Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potential

অনুযায়ী Bersanelli, Melissa, Buti, Sebastiano
প্রকাশিত Ther Adv Med Oncol (2017)

Spotlight on cabozantinib for previously untreated advanced renal cell carcinoma: evidence to date

অনুযায়ী Bersanelli, Melissa, Leonardi, Francesco, Buti, Sebastiano
প্রকাশিত Cancer Manag Res (2018)

The way towards tailored treatment for metastatic renal cancer patients in the omics era: are we getting a “transcriptomic compass”?

অনুযায়ী Bersanelli, Melissa, Cortellini, Alessio, Buti, Sebastiano
প্রকাশিত Ann Transl Med (2019)

The interplay between cholesterol (and other metabolic conditions) and immune-checkpoint immunotherapy: shifting the concept from the “inflamed tumor” to the “inflamed patient”...

অনুযায়ী Bersanelli, Melissa, Cortellini, Alessio, Buti, Sebastiano
প্রকাশিত Hum Vaccin Immunother (2021)

Systemic adjuvant therapies in renal cell carcinoma

অনুযায়ী Buti, Sebastiano, Bersanelli, Melissa, Donini, Maddalena, Ardizzoni, Andrea
প্রকাশিত Oncol Rev (2012)

Metabolic complete response with vinflunine as second-line therapy in a kidney-transplanted patient with advanced urothelial carcinoma: a case report

অনুযায়ী Bordi, Paola, Tiseo, Marcello, Baldari, Giorgio, Buti, Sebastiano
প্রকাশিত BMC Cancer (2016)

Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy

অনুযায়ী Buti, Sebastiano, Leonetti, Alessandro, Dallatomasina, Alice, Bersanelli, Melissa
প্রকাশিত Core Evid (2016)

Clinical use of lenvatinib in combination with everolimus for the treatment of advanced renal cell carcinoma

অনুযায়ী Leonetti, Alessandro, Leonardi, Francesco, Bersanelli, Melissa, Buti, Sebastiano
প্রকাশিত Ther Clin Risk Manag (2017)

Family history of cancer and DNA damage response genes: Two sides of the same coin?

অনুযায়ী Cortellini, Alessio, Bersanelli, Melissa, Ficorella, Corrado, Buti, Sebastiano
প্রকাশিত Thorac Cancer (2018)

Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives

অনুযায়ী Facchinetti, Francesco, Bordi, Paola, Leonetti, Alessandro, Buti, Sebastiano, Tiseo, Marcello
প্রকাশিত Drug Des Devel Ther (2018)

Pathological nodal staging score for renal cell carcinoma: how to build reliable therapeutic choices basing on assumptions

অনুযায়ী Bersanelli, Melissa, Buti, Sebastiano, Santoni, Matteo, Ziglioli, Francesco, Maestroni, Umberto
প্রকাশিত Ann Transl Med (2019)

Pazopanib as a possible option for the treatment of metastatic non-clear cell renal carcinoma patients: a systematic review

অনুযায়ী Bersanelli, Melissa, Brunelli, Matteo, Gnetti, Letizia, Maestroni, Umberto, Buti, Sebastiano
প্রকাশিত Ther Adv Med Oncol (2020)

Role of stereotactic body radiation therapy for the management of renal cell carcinoma: tailoring treatment in the era of the “embarrassment of riches”

অনুযায়ী Buti, Sebastiano, Leonetti, Alessandro, Lattanzi, Elisabetta, D’Abbiero, Nunziata, Bersanelli, Melissa
প্রকাশিত Ann Transl Med (2019)

Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study

অনুযায়ী Buti, Sebastiano, Donini, Maddalena, Bersanelli, Melissa, Gattara, Alessia, Leonardi, Francesco, Passalacqua, Rodolfo
প্রকাশিত Drugs R D (2017)

Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study

অনুযায়ী Buti, Sebastiano, Donini, Maddalena, Bersanelli, Melissa, Gattara, Alessia, Leonardi, Francesco, Passalacqua, Rodolfo
প্রকাশিত Drugs R D (2018)

Gefitinib Plus Interleukin-2 in Advanced Non-Small Cell Lung Cancer Patients Previously Treated with Chemotherapy

অনুযায়ী Bersanelli, Melissa, Buti, Sebastiano, Camisa, Roberta, Brighenti, Matteo, Lazzarelli, Silvia, Mazza, Giancarlo, Passalacqua, Rodolfo
প্রকাশিত Cancers (Basel) (2014)

Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?

অনুযায়ী Roviello, Giandomenico, Buti, Sebastiano, Cattrini, Carlo, Mennitto, Alessia, Messina, Carlo, Airoldi, Chiara, Vannini, Gianmarco, Bersanelli, Melissa
প্রকাশিত Ther Adv Urol (2021)

The right immune-modulation at the right time: thymosin α1 for prevention of severe COVID-19 in cancer patients

অনুযায়ী Bersanelli, Melissa, Giannarelli, Diana, Leonetti, Alessandro, Buti, Sebastiano, Tiseo, Marcello, Nouvenne, Antonio, Ticinesi, Andrea, Meschi, Tiziana, Procopio, Giuseppe, Danielli, Riccardo
প্রকাশিত Future Oncol (2021)

CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors

অনুযায়ী Dall’Olio, Filippo G., Abbati, Francesca, Facchinetti, Francesco, Massucci, Maria, Melotti, Barbara, Squadrilli, Anna, Buti, Sebastiano, Formica, Francesca, Tiseo, Marcello, Ardizzoni, Andrea
প্রকাশিত Ther Adv Med Oncol (2020)